Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) traded down 3% on Thursday . The stock traded as low as $27.57 and last traded at $27.89. 552,733 shares were traded during mid-day trading, a decline of 75% from the average session volume of 2,206,098 shares. The stock had previously closed at $28.76. Wall Street Analysts […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report)’s stock price was down 3% during mid-day trading on Thursday . The stock traded as low as $27.57 and last traded at $27.89. Approximately 552,733 shares were traded during trading, a decline of 75% from the average daily volume of 2,206,098 shares. The stock had previously closed […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven analysts that are covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been given an average rating of “Buy” by the seven research firms that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month […]
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price target hoisted by Chardan Capital from $20.00 to $31.00 in a research note issued to investors on Friday, Stock Target Advisor reports. The brokerage currently has a buy rating on the stock. Several other research firms have also weighed in on DYN. StockNews.com upgraded shares of […]